Copyright © 2016 UCSD ADRC.
All rights reserved.

Resveratrol (ADC-037-RES)

PI: Mike Rafii, MD, PhD / Judith Rivera, NP / Holly Bowron Hainley, NP



Time Involved


12 months



Phase II, double-blind, placebo-controlled, parallel arm drug trial to evaluate the safety, tolerability and effectiveness of resveratrol when given to people with mild to moderate AD. All participants will undergo CSF collection (lumbar puncture) and volumetric MRI.



  • Age 50 or older
  • Mild to moderate AD
  • MMSE 14-26 (inclusive)
  • Have a study partner
  • Able to abstain from ingesting large quantities of resveratrol containing foods (red wine, red grapes, or red grape juice)
  • Able to abstain from ingesting herbal/natural dietary supplements containing resveratrol.




Jennifer Foster (858) 246-1306